Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

Abstract

Tumorigenesis is a multistep process, with oncogenic mutations in a normal cell conferring clonal advantage as the initial event. However, despite pervasive somatic mutations and clonal expansion in normal tissues, their transformation into cancer remains a rare event, indicating the presence of additional driver events for progression to an irreversible, highly heterogeneous, and invasive lesion. Recently, researchers are emphasizing the mechanisms of environmental tumor risk factors and epigenetic alterations that are profoundly influencing early clonal expansion and malignant evolution, independently of inducing mutations. Additionally, clonal evolution in tumorigenesis reflects a multifaceted interplay between cell-intrinsic identities and various cell-extrinsic factors that exert selective pressures to either restrain uncontrolled proliferation or allow specific clones to progress into tumors. However, the mechanisms by which driver events induce both intrinsic cellular competency and remodel environmental stress to facilitate malignant transformation are not fully understood. In this review, we summarize the genetic, epigenetic, and external driver events, and their effects on the co-evolution of the transformed cells and their ecosystem during tumor initiation and early malignant evolution. A deeper understanding of the earliest molecular events holds promise for translational applications, predicting individuals at high-risk of tumor and developing strategies to intercept malignant transformation.

References 533

1. 1.
   A New, Quantitative, Approach to the Study of the Stages of Chemical Carcinogenesis in the Mouse's Skin · 1947

   No notice
2. 2.
   Cancer as a disease of old age: changing mutational and microenvironmental landscapes · 2020

   No notice
3. 3.

   Kakiuchi N, Ogawa S. Clonal expansion in non-cancer tissues. Nat. Rev. Cancer. 2021;21:239-256.

   Not in our library10.1038/s41568-021-00335-3

4. 4.

   Crosby D, et al. Early detection of cancer. Science. 2022;375:eaay9040.

   Not in our library10.1126/science.aay9040

5. 5.

   Martin GS. The road to Src. Oncogene. 2004;23:7910-7917.

   Not in our library10.1038/sj.onc.1208077

6. 6.

   Boveri T. The Origin of Malignant Tumors. Arch. Intern. Med. 1929;44:910.

   Not in our library10.1001/archinte.1929.00140060125019

7. 7.
   A New Theory on the Cancer-inducing Mechanism · 1953

   No notice
8. 8.

   Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer. 2004;91:1983-1989.

   Not in our library10.1038/sj.bjc.6602297

9. 9.

   Huebner RJ, Todaro GJ. Oncogenes of RNA tumor viruses as determinants of cancer. Proc. Natl Acad. Sci. USA. 1969;64:1087-1094.

   Not in our library10.1073/pnas.64.3.1087

10. 10.

    Weiss R. Molecular analysis of the oncogene. Nature. 1976;260:93-93.

    Not in our library10.1038/260093a0

11. 11.

    Klein G, Klein E. Evolution of tumours and the impact of molecular oncology. Nature. 1985;315:190-195.

    Not in our library10.1038/315190a0

12. 12.

    Parada LF, Tabin CJ, Shih C, Weinberg RA. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature. 1982;297:474-478.

    Not in our library10.1038/297474a0

13. 13.

    Santos E, et al. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB-and Harvey-MSV transforming genes. Nature. 1982;298:343-347.

    Not in our library10.1038/298343a0

14. 14.

    Martínez-Jiménez F, et al. A compendium of mutational cancer driver genes. Nat. Rev. Cancer. 2020;20:555-572.

    Not in our library10.1038/s41568-020-0290-x

15. 15.

    Hudson TJ, et al. International network of cancer genome projects. Nature. 2010;464:993-998.

    Not in our library10.1038/nature08987

16. 16.
    Pan-cancer analysis of whole genomes · 2020

    Corrected
17. 17.

    Greenman C, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446:153-158.

    Not in our library10.1038/nature05610

18. 18.

    Dressler L, et al. Comparative assessment of genes driving cancer and somatic evolution in non-cancer tissues: an update of the Network of Cancer Genes (NCG) resource. Genome Biol. 2022;23:35.

    Not in our library10.1186/s13059-022-02607-z

19. 19.

    Fowler JC, Jones PH. Somatic mutation: What shapes the mutational landscape of normal epithelia? Cancer Discov. 2022;12:1642-1655.

    Not in our library10.1158/2159-8290.cd-22-0145

20. 20.

    Triolo VA. Nineteenth century foundations of cancer research advances in tumor pathology, nomenclature, and theories of oncogenesis. Cancer Res. 1965;25:75-106.

    Not in our library

21. 21.

    Watanabe T, Dewey MJ, Mintz B. Teratocarcinoma cells as vehicles for introducing specific mutant mitochondrial genes into mice. Proc. Natl. Acad. Sci. USA. 1978;75:5113-5117,.

    Not in our library10.1073/pnas.75.10.5113

22. 22.

    Dolberg DS, Hollingsworth R, Hertle M, Bissell MJ. Wounding and its role in RSV-mediated tumor formation. Science. 1985;230:676-678,.

    Not in our library10.1126/science.2996144

23. 23.

    Sieweke MH, Thompson NL, Sporn MB, Bissell MJ. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. Science. 1990;248:1656-1660,.

    Not in our library10.1126/science.2163544

24. 24.

    Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 2000;60:1254-1260,.

    Not in our library

25. 25.

    Maffini MV, et al. The stroma as a crucial target in rat mammary gland carcinogenesis. J. Cell Sci. 2004;117:1495-1502.

    Not in our library10.1242/jcs.01000

26. 26.

    Soto AM, Sonnenschein C. The tissue organization field theory of cancer: A testable replacement for the somatic mutation theory. Bioessays. 2011;33:332-340.

    Not in our library10.1002/bies.201100025

27. 27.

    Rozenblatt-Rosen O, et al. The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution. Cell. 2020;181:236-249.

    Not in our library10.1016/j.cell.2020.03.053

28. 28.
    Epigenetic regulation during cancer transitions across 11 tumour types · 2023

    No notice
29. 29.

    Liang WW, et al. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin. Cancer Cell. 2023;41:1567-1585.e1567.

    Not in our library10.1016/j.ccell.2023.07.013

30. 30.

    Li Y, et al. Pan-cancer proteogenomics connects oncogenic drivers to functional states. Cell. 2023;186:3921-3944.e3925.

    Not in our library10.1016/j.cell.2023.07.014

31. 31.

    Geffen Y, et al. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell. 2023;186:3945-3967.e3926.

    Not in our library10.1016/j.cell.2023.07.013

32. 32.

    Kinker GS, et al. Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity. Nat. Genet. 2020;52:1208-1218.

    Not in our library10.1038/s41588-020-00726-6

33. 33.

    Barkley D, et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat. Genet. 2022;54:1192-1201.

    Not in our library10.1038/s41588-022-01141-9

34. 34.

    Gavish A, et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature. 2023;618:598-606.

    Not in our library10.1038/s41586-023-06130-4

35. 35.

    Alexandrov LB, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415-421.

    Not in our library10.1038/nature12477

36. 36.

    Mustjoki S, Young NS. Somatic mutations in “Benign” disease. N. Engl. J. Med. 2021;384:2039-2052.

    Not in our library10.1056/nejmra2101920

37. 37.

    Li R, et al. A body map of somatic mutagenesis in morphologically normal human tissues. Nature. 2021;597:398-403.

    Not in our library10.1038/s41586-021-03836-1

38. 38.

    Moore L, et al. The mutational landscape of human somatic and germline cells. Nature. 2021;597:381-386.

    Not in our library10.1038/s41586-021-03822-7

39. 39.

    Li R, et al. Macroscopic somatic clonal expansion in morphologically normal human urothelium. Science. 2020;370:82-89.

    Not in our library10.1126/science.aba7300

40. 40.

    Yizhak K, et al. RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues. Science. 2019;364:eaaw0726.

    Not in our library10.1126/science.aaw0726

Cited by papers we hold 2

• Lung Cancer—Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature) · 2025
  No notice
• Free radicals and their impact on health and antioxidant defenses: a review · 2025
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.